JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) fact sheet on November 4, 2026 for Market Linked Securities due November 9, 2028, linked to the lowest performing of Arista Networks, Marvell Technology, and Amazon.com common stock.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 5, 2026, disclosing the terms of auto callable accelerated barrier notes linked to the Nasdaq-100 Technology Sector Index and the Russell 2000 Index, with a pricing date of November 25, 2026, …
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 5, 2026, disclosing terms for its 15-month S&P 500 Capped Buffered Return Enhanced Notes with a pricing date of November 30, 2026, and a maturity date of March 3, 2028.
JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 4, 2026, disclosing terms for 2-Year RTY/NDX/SX5E Contingent Income Callable Securities with an expected pricing date of November 11, 2026, and a maturity date of November 16, 2028.
Prospect Capital Corporation filed a Form 8-K on November 5, 2026, reporting its fiscal quarter results for the period ended September 30, 2026, and announcing the declaration of monthly and quarterly cash distributions across its common stock and five preferred stock classes.
United Parcel Service, Inc. filed a Form 8-K on November 5, 2026, disclosing the appointment of Shannon Eisenhardt to its Board of Directors and Audit Committee, effective November 4, 2026.
News Corporation filed a Form 8-K on November 5, 2026, reporting its provision of stock repurchase transaction disclosures to the Australian Securities Exchange, as required under ASX rules, covering activity dated November 4, 2026.
EPAM Systems, Inc. filed a Form 8-K on November 5, 2026, disclosing third-quarter 2026 operating results and a new Board-approved common stock repurchase program of up to $1.8 billion, replacing the prior $1 billion authorization.
Our Bond, Inc. filed a Form 8-K on November 5, 2026, disclosing that founder and Chief Executive Officer Doron Kempel would host a live webinar that same day at 11:00 AM Eastern Time.
BioxyTran, Inc. filed a Form 8-K on November 5, 2026, disclosing that on November 4, 2026, the company announced it had secured an Attested Free Sale Certification for its product A-SUQAR, described as opening a path to the UAE and Gulf markets.